Taro Pharmaceuticals U.S.A., Inc. Recalls

1 recall found for Taro Pharmaceuticals U.S.A., Inc.. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

Taro Pharmaceuticals Recalls Clindamycin Phosphate Over Impurities

Taro Pharmaceuticals recalled Clindamycin Phosphate USP, 1% topical solution on November 26, 2025. The recall affects specific lots due to failed impurity testing. Consumers should stop using the product immediately and consult healthcare providers.

CLINDAMYCIN PHOSPHATE
Failed Impurities/Degradation:
Read more

Brand Statistics

Total Recalls
1
Pages
1

Related Brands

CLINDAMYCIN PHOSPHATE
    Taro Pharmaceuticals U.S.A., Inc. Recalls | RecallRadar